Aldeyra Therapeutics Inc (ALDX) Stock Price, Quote, News & History

ALDXNASDAQ
$1.99
-0.085-4.11%
Last update: Jul 13, 11:43 AM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-25.99M
Investing Cash Flow (TTM)
40.45M
Financing Cash Flow (TTM)
191.89K
Free Cash Flow (TTM)
-25.99M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
14.65M

Analyst Trends and Forecast

1
Mar
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$75.33M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
2.96
Earnings Yield % (TTM)
-21.75%
Earnings Yield % (FWD)
-20.78%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.70

Company Debt

Total Debt
$15.30M
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$65.00M
Debt to Equity
0.37
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$2.03
Close
-
Volume / Avg.
461.70K / 1.42M
Day Range
$1.93 - $2.06
52 Wk Range
1.07 - 6.18
Market Cap
$119.74M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
50
Short Interest
9.72%
Days to Cover
2.5

About

Sector
Health Care
Industry
Biotechnology
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a tr...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Aldeyra Therapeutics (ALDX) stock?

A

You can purchase shares of Aldeyra Therapeutics (NASDAQ:ALDX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Aldeyra Therapeutics (ALDX) competitors?

A

There are no as such competitors for Aldeyra Therapeutics.

Q

What is the forecast, or price target, for Aldeyra Therapeutics (ALDX) stock?

A

Aldeyra Therapeutics has a consensus price target of $7.25.

Q

What is the current price for Aldeyra Therapeutics (ALDX)?

A

The stock price for Aldeyra Therapeutics (NASDAQ: ALDX) is $1.985 last updated July 13, 2026 at 11:43 AM EDT.

Q

Does Aldeyra Therapeutics (ALDX) pay a dividend?

A

There are no upcoming dividends for Aldeyra Therapeutics.

Q

When is Aldeyra Therapeutics (NASDAQ:ALDX) reporting earnings?

A

Aldeyra Therapeutics does not have any upcoming earnings scheduled.

Q

Is Aldeyra Therapeutics (ALDX) going to split?

A

There is no upcoming split for Aldeyra Therapeutics.

Q

What sector and industry does Aldeyra Therapeutics (ALDX) operate in?

A

Aldeyra Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.